Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.152.313.244.014.89

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.15 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.15
Mar20232.31
Mar20223.24
Mar20214.01
Mar20204.89

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01
-18.00
Mar2020 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹410.9 Cr 5.3% -10.7% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,478.0 Cr -1.3% -4.8% 45% Stock Analytics
DIVIS LABORATORIES ₹163,822.0 Cr 0.5% 6.4% 58.2% Stock Analytics
CIPLA ₹123,920.0 Cr 2.1% 3.8% 24.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,322.0 Cr -0.6% -5.7% 5.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,217.3 Cr 0.1% -3.6% 48.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

5.3%

-10.7%

-19.6%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses